Artificial intelligence, Parkinson's disease, PET molecular imaging, Medical imaging, Meta-analysis
Parkinson's disease, differential diagnosis, artificial intelligence, 18F-fluorodeoxyglucose positron emission tomography, imaging-based biomarker, deep learning, deep neural network, saliency map, multiple system atrophy, progressive supranuclear palsy